BEAM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

22.33

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.29

EPS Last/This Y

-3.7

EPS This/Next Y

-0.31

Price

28.64

Target Price

50.19

Analyst Recom

1.28

Performance Q

1.09

Upside

-131.3%

Beta

2.23

Ticker: BEAM

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	BEAM	30.14	0.21	1.09	13070
2026-04-24	BEAM	27.1	0.21	1.78	13112
2026-04-27	BEAM	29.17	0.25	0.07	13467
2026-04-28	BEAM	30.57	0.24	0.29	14011
2026-04-29	BEAM	29.39	0.24	1.29	14033
2026-04-30	BEAM	30.32	0.25	0.27	14106
2026-05-01	BEAM	30.71	0.25	0.81	14120
2026-05-04	BEAM	30.09	0.24	0.25	14085
2026-05-05	BEAM	28.89	0.24	1.33	14120
2026-05-06	BEAM	32.34	0.27	0.23	14500
2026-05-07	BEAM	31.44	0.27	0.37	14525
2026-05-08	BEAM	32.34	0.27	0.10	14773
2026-05-11	BEAM	31.74	0.27	0.13	15032
2026-05-12	BEAM	31.57	0.24	0.66	16786
2026-05-13	BEAM	31.84	0.24	0.53	16858
2026-05-14	BEAM	29.55	0.24	0.76	16904
2026-05-15	BEAM	27.93	0.25	0.24	17041
2026-05-18	BEAM	26.81	0.16	0.64	13313
2026-05-19	BEAM	26.34	0.17	1.53	13778
2026-05-20	BEAM	27.09	0.20	0.02	14464
2026-05-21	BEAM	27.67	0.20	0.07	14925
2026-05-22	BEAM	28.63	0.19	0.23	15265
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	BEAM	30.17	18.4	-	-4.31
2026-04-24	BEAM	27.10	18.4	-	-4.31
2026-04-27	BEAM	29.17	18.4	-	-4.31
2026-04-28	BEAM	30.58	18.4	-	-4.31
2026-04-30	BEAM	30.31	18.4	-	-4.31
2026-05-01	BEAM	30.70	18.4	-	-4.31
2026-05-04	BEAM	30.08	18.4	-	-4.31
2026-05-05	BEAM	28.88	18.4	-	-4.31
2026-05-06	BEAM	32.33	18.4	-	-4.31
2026-05-07	BEAM	31.46	18.4	-	-4.31
2026-05-08	BEAM	32.34	18.4	-	-4.31
2026-05-11	BEAM	31.75	-23.0	-	-4.32
2026-05-12	BEAM	31.58	-16.8	-	-4.52
2026-05-13	BEAM	31.83	-14.6	-	-4.52
2026-05-14	BEAM	29.52	-14.6	-	-4.48
2026-05-15	BEAM	27.93	-14.6	-	-4.48
2026-05-18	BEAM	26.79	-14.5	-	-4.51
2026-05-19	BEAM	26.32	-14.5	-	-4.51
2026-05-20	BEAM	27.09	-14.5	-	-4.51
2026-05-21	BEAM	27.67	-14.5	-	-4.51
2026-05-22	BEAM	28.64	-14.5	-	-4.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	BEAM	-2.50	3.56	25.19
2026-04-24	BEAM	-2.46	3.56	25.19
2026-04-27	BEAM	-2.44	3.20	23.76
2026-04-28	BEAM	-2.44	3.20	23.76
2026-04-29	BEAM	-2.44	3.20	23.76
2026-04-30	BEAM	-2.43	3.20	23.76
2026-05-01	BEAM	-2.43	3.20	23.76
2026-05-04	BEAM	-2.43	4.12	23.76
2026-05-05	BEAM	-2.43	4.12	23.76
2026-05-06	BEAM	-2.43	4.12	23.76
2026-05-07	BEAM	-2.43	4.12	23.76
2026-05-08	BEAM	-2.43	4.12	23.76
2026-05-11	BEAM	-2.43	4.33	23.73
2026-05-12	BEAM	-2.43	4.33	22.35
2026-05-13	BEAM	-2.43	4.33	22.35
2026-05-14	BEAM	-2.43	4.33	22.33
2026-05-15	BEAM	-2.45	4.33	22.33
2026-05-18	BEAM	-2.45	4.21	22.33
2026-05-19	BEAM	-2.45	4.21	22.33
2026-05-20	BEAM	-2.45	4.21	22.33
2026-05-21	BEAM	-2.45	4.21	22.33
2026-05-22	BEAM	-2.45	4.21	22.33
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.91

Avg. EPS Est. Current Quarter

-1.15

Avg. EPS Est. Next Quarter

-1.2

Insider Transactions

-2.45

Institutional Transactions

4.21

Beta

2.23

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

79.3

Max Drawdown 5-Year %

-89.1

Target Price

50.19

P/E

Forward P/E

PEG

P/S

17.97

P/B

2.53

P/Free Cash Flow

EPS

-0.69

Average EPS Est. Cur. Y

-4.51

EPS Next Y. (Est.)

-4.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-39.66

Relative Volume

0.62

Return on Equity vs Sector %

-32.7

Return on Equity vs Industry %

-17.1

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.19

EBIT Estimation

◆ BEAM Healthcare

$28.64

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

19/25

Volume

9/15

Valuation

10/20

TP/AR

4/10

Options

7/10

RSI

48.7

Range 1M

31.5%

Sup Dist

7.3%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

13/30

Estimates

4/20

Inst/Vol

6/15

Options

10/10

EPS Yr

-445.8%

EPS NY

0.4%

52W%

62.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +75.2% upside

Quality

7/30

Valuation

14/30

Growth

9/25

Stability

9/10

LT Trend

3/5

Upside

+75.2%

Quality

Beam Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 522

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of severe alpha-1 antitrypsin deficiency; BEAM-304, a liver-targeting LNP for the treatment of phenylketonuria; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease type 1a. The company also develops the ESCAPE platform, which combines antibody-based conditioning with multiplex gene edited HSCs. In addition, it develops BEAM-103, an anti-CD117 monoclonal antibody that enables ESCAPE. The company has research collaboration agreement with Pfizer Inc., focusing on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Verve Therapeutics, Inc., for cardiovascular disease treatments; and Orbital Therapeutics to design RNA for the prevention, treatment, or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

BEAM

Latest News

—

Caricamento notizie per BEAM…

stock quote shares BEAM – Beam Therapeutics Inc. Stock Price stock today

news today BEAM – Beam Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BEAM – Beam Therapeutics Inc. yahoo finance google finance

stock history BEAM – Beam Therapeutics Inc. invest stock market

stock prices BEAM premarket after hours

ticker BEAM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: BEAM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y